查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844121

長讀長定序市場按產品/服務、技術、應用和最終用戶分類 - 全球預測 2025-2032

Long Read Sequencing Market by Product & Service, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，長讀定序市場將成長至 58.2348 億美元，複合年成長率為 27.01%。

主要市場統計數據
基準年 2024 8.598億美元
預計年份：2025年 10.9712億美元
預測年份：2032年 5,823,480,000 美元
複合年成長率 (%) 27.01%

這是一篇簡潔而權威的介紹，解釋了長讀定序如何發展成為一個策略平台，正在重塑研究、診斷和應用基因組學。

長讀長定序已從一項專門的研究能力轉變為一個策略平台，重塑了基因組研究、臨床轉化流程和應用生命科學。該技術能夠分析複雜的基因組區域，檢測長單倍型中的等位基因同源性，並檢測天然分子中的結構變異和表觀遺傳標記，為短讀長測序方法無法可靠解決的應用開闢了無限可能。因此，研究機構、診斷實驗室和企業正在重新評估其技術架構、工作流程和供應商關係，以充分利用長讀長定序帶來的科學和營運優勢。

同時，化學、孔隙工程、儀器設計和生物資訊學的進步正在簡化樣品製備，同時提高讀取的準確性和通量。這些技術進步，加上分析工具和雲端工作流程的普及，降低了進入門檻，並將使用者群體擴展到專業定序中心之外。因此，各機構正從概念驗證研究轉向在腫瘤學、病原體監測、作物改良和精準醫療等領域常規應用長讀長定序技術。

從實驗級操作過渡到生產級操作需要關注可重複性、法規遵循和供應連續性。因此，希望利用長讀長定序技術的實驗室必須整合穩健的資料管理、驗證實務和與供應商無關的品管，以確保科學研究成果能夠轉化為實際營運效益和可靠的臨床或監管產出。

展望未來，探討技術、商業性和工作流程的轉變如何重新定義各領域的長讀長定序應用和營運模式。

長讀長定序領域正經歷顯著的變革，這主要得益於技術的成熟、工作流程的整合以及終端使用者需求的不斷變化。硬體和化學技術的進步提高了單次定序的準確性和運作穩定性，而模組化的儀器架構則實現了從桌上型到高通量中心的可擴展通量。同時，即時鹼基辨識和天然表觀遺傳檢測技術的出現，催生了新的應用場景，在這些場景中，快速週轉和多層次的分子資訊至關重要。

同時，軟體生態系統正從客製化的學術腳本轉向強調可復現性、可復現流程和法規遵循的企業級解決方案。雲端原生分析框架、容器化和標準化API實現了跨平台互通性，降低了臨床實驗室和合約研究組織（CRO）採用長讀長工作流程的門檻。此外，耗材的商品化以及試劑生產中對永續性的關注也正在影響籌資策略和長期營運成本。

這種轉變也體現在市場動態中，供應商正在使其商業模式多元化，包括提供儀器服務、訂閱式耗材計劃以及將定序與生物資訊學和維護相結合的整合服務。隨著各機構重新思考其長期投資，關注點正轉向總體擁有成本、生命週期支援以及技術合作夥伴提供符合監管和臨床級要求的檢驗工作流程的能力。

對截至2025年美國累積關稅如何改變定序生態系統中的籌資策略、供應韌性和供應商應對措施進行深入評估

美國在2025年前逐步實施的累積關稅政策，為長讀長定序生態系統的採購、供應鏈韌性和籌資策略帶來了新的挑戰。進口設備和關鍵試劑關稅的提高迫使企業重新評估供應商關係和庫存策略，以降低成本波動和前置作業時間風險。為此，許多相關人員優先考慮供應商多元化，為流動池和專用試劑套件等關鍵耗材建立緩衝庫存，並重新評估服務合約以鎖定價格和交貨時間。

為了降低跨境關稅的影響，製造商和經銷商紛紛調整策略，探索在岸組裝、區域配送中心以及與當地製造商建立合作關係。對顧客而言，關稅環境使產品生命週期規劃更加複雜。由於負責人需要進行更全面的總成本分析，並尋求簽訂多年服務協議以管理關稅實施後的營運預算，採購週期也隨之延長。同時，一些供應商透過價格策略來維持裝置量的忠誠度，從而承擔了部分成本上漲；而另一些供應商則加快了對區域製造的投資，以重獲競爭優勢並縮短供應鏈。

整體而言，關稅凸顯了供應鏈透明度、合約彈性和情境規劃的策略價值。積極主動模擬關稅風險、協商彈性條款並制定替代籌資策略的機構，將更有利於維持研究的連續性、保障臨床工作流程，並確保產品開發和發現的進度符合市場競爭要求。

深入分析並綜合產品、技術、應用和最終用戶等維度上的細微細分動態，為策略優先排序提供基礎。

細分市場層面的動態揭示了產品和服務、技術、應用以及最終用戶群體之間存在的差異化促進因素，這些差異對於策略定位至關重要。在產品和服務領域，耗材（包括流動池、套件和試劑）的經常性收入仍然是業務營運的核心考慮因素，因為它們的可靠性和供應的連續性直接影響通量和實驗的可重複性。對定序系統和配套附件的投資決定了資本規劃週期，而生物資訊服務、數據分析軟體和維護服務則決定了長期營運支援和監管合規性。

在各個技術領域，奈米孔定序已發展成為一種高度可攜式、即時回應的解決方案，適用於現場部署和快速監測；而單分子即時定序則憑藉其高單次讀取準確率和環狀共識方法，鞏固了其市場地位。合成長讀長定序策略繼續為某些基因組組裝工作和大規模基因組計劃提供經濟高效的替代方案，在這些計畫中，從連接讀段重建遠距資訊具有優勢。

在農業基因組學中，長讀長定序可用於結構變異檢測和複雜性狀定位；在癌症基因組學中，長程定相用於揭示腫瘤異質性；在臨床研究中，長程定相用於轉化研究中的全面變異檢測；在微生物基因組學中，長讀長測序用於質體解析和疫情追蹤。不同的最終用戶有不同的重點：學術中心專注於方法創新和新的應用案例；臨床診斷實驗室優先考慮驗證、通量和合規性；受託研究機構為多個客戶提供承包測序服務；政府和監管機構側重於監測和標準化；而製藥和生物技術公司則將長讀長測序整合到其靶點發現和生物標記檢驗工作中。

區域比較情報觀點，展現了全球主要區域在採用促進因素、法律規範和商業生態系統方面的差異

區域動態反映了研究基礎設施、法規環境和商業生態系統的差異，進而影響技術的應用管道和競爭重點。在美洲，強大的學術研究網路、密集的臨床實驗室活動以及成熟的供應商基礎正在加速高精度、長讀長定序技術在腫瘤學、神經基因組學和微生物監測領域的應用。該地區也展現出成熟的公私合營模式，將定序儀整合到公共衛生舉措和轉化計畫中。

在歐洲、中東和非洲，監管協調工作和泛歐聯盟正在推動對參考基因組、監測網路和跨境資料共用的協調投資。該地區的研究資助模式通常強調共享基礎設施和標準化通訊協定，從而影響採購週期以及對檢驗的工作流程和符合規範的軟體的需求。多語言市場和多元化的醫療保健系統凸顯了在地化支援和跨司法管轄區監管專業知識的重要性。

在亞太地區，資本的快速投入、國內製造能力的擴張以及農業基因組學和感染疾病監測領域的活性化，正在加速技術的應用和創新。區域參與企業通常優先考慮能夠兼顧吞吐量和成本效益的可擴展平台，而區域內的跨境合作正在促進生態系統的發展。這些區域差異提示了市場進入策略、夥伴關係模式以及對本地支援和供應鏈韌性的投資重點方向。

企業行為的策略性回顧，揭示了平台創新、整合服務和不斷演進的商業模式如何塑造競爭優勢。

長讀長定序領域的企業策略正圍繞著幾個共同的主題：提昇平台效能、最佳化耗材生命週期管理、整合軟體和服務以及建立合作夥伴關係。主要儀器供應商正增加對化學創新和孔徑設計的投入，以降低誤差率並提高通量，同時擴展儀器外形尺寸，以適應更廣泛的實驗室空間。除了硬體方面的進步，各公司也正在加速開發分析套件和託管服務，以消除臨床和工業用戶在使用經過檢驗的端到端工作流程時遇到的障礙。

同時，商業模式也變得更靈活。基於訂閱的儀器使用、試劑捆綁銷售和全面的支援服務包正逐漸成為傳統資本購買模式的可行替代方案。試劑生產商、雲端分析提供者和學術聯盟之間的策略夥伴關係正被用於拓展目標市場並加速特定應用領域的檢驗，例如腫瘤基因組檢測、作物基因組分析流程和病原體監測通訊協定。服務供應商和合約研究組織（CRO）正在擴展其能力，以提供專業的長讀長定序服務，使客戶能夠在確保資料管治和品質的前提下外包定序和分析工作。

最後，企業正優先考慮供應鏈多元化和本地化生產，以降低關稅和物流風險。那些擁有強大的研發藍圖、透明的服務等級協定和在地化支援體系的企業，對尋求長期夥伴關係的大型機構和企業客戶而言，正變得越來越有吸引力。

為平衡供應鏈韌性、生物資訊投資、監管參與和以客戶為中心的商業模式，提出切實可行的建議

產業領導者應採取組合策略，兼顧短期業務永續營運和長期策略差異化。首先，他們應透過建立關鍵耗材（如流動池和特種試劑）的多源採購策略來增強供應鏈韌性，並在適當情況下簽訂多年期契約，同時評估區域分銷或組裝方案，以降低跨境關稅波動帶來的風險。其次，他們應優先投資於生物資訊學和數據管理。標準化、檢驗的流程和健全的資料管治能夠加速臨床應用，並支持跨機構合作。

第三，我們透過為學術研究機構提供靈活的採購選項、為臨床診斷客戶提供檢驗的承包解決方案以及為委外研發機構提供可擴展的服務包，使我們的產品和商業模式與終端用戶的獨特需求保持一致。第四，我們積極與監管相關人員溝通並參與標準化項目，以確保新的工作流程符合不斷變化的合規要求，並縮短臨床驗證所需的時間。第五，我們投資於培訓和現場支持，以減少實施過程中的阻力。為實驗室人員和轉化科學家提供的實踐培訓可以提高工作效率並降低錯誤率。

將這些措施結合起來，將使各組織能夠利用其科學優勢，確保營運連續性，並將技術領先地位轉化為其研究項目、臨床服務和產品開發平臺的可衡量成果。

對用於綜合分析技術趨勢、相關人員觀點和市場區隔等方面的洞察的依證和分析過程進行透明描述。

本執行摘要的研究結合了結構化的二手資料分析、專家訪談和跨來源檢驗，以確保其嚴謹性和有效性。二手資料分析包括對同行評審文獻、專利活動、公開產品公告、監管文件和技術白皮書的系統性回顧，旨在描繪技術發展軌跡和創新熱點。這些資訊來源被整合起來，用於識別新興的績效基準、工作流程轉變和商業模式創新。

為了補充文獻綜述，我們對實驗室主任、技術採用者、採購負責人和行業策略家進行了定性訪談，以將技術趨勢與實際營運情況和採購限制聯繫起來。訪談內容幫助我們解讀了供應商策略、顧客痛點以及關稅主導的供應鏈轉型所帶來的實際影響。我們對來自資訊來源的研究結果進行了三角驗證，以減少偏差並識別反覆出現的主題。

最後，我們應用了一個細分框架，從產品類型、技術類型、應用領域和最終用戶畫像等方面深入了解市場。調查方法的局限性包括設備性能聲明的不斷變化以及專有技術發布可能存在的延遲。因此，該調查方法強調假設的透明度，並鼓勵對投資決策和採購承諾進行後續檢驗。

綜合各項研究結果，重點闡述為最大限度發揮長讀長定序創新技術的價值所需的策略要務與營運重點。

長讀長定序正處於曲折點，技術進步、應用拓展和商業性實踐的演進將為研究機構、臨床實驗室和商業性生命科學組織創造持久的策略價值。它能夠提供遠距基因組資訊、原生檢測表觀遺傳標記並解析結構複雜性，這將推動腫瘤學、微生物監測、農業育種和轉化檢驗等領域的進步。結合對經過驗證的分析技術和穩健供應鏈的投資，這些技術優勢將轉化為實際的營運和策略效益。

然而，要充分發揮這種潛力，需要採取檢驗行動，例如優先考慮受法規環境的工作流程、在耗材採購中建立冗餘機制，以及投資於能夠確保可重複性和合規性的軟體和服務。那些將採購、研發計畫和夥伴關係策略與這些必要條件相契合的相關人員，最能從中獲取持久價值。相反，那些延遲將長讀長數據整合到其流程中的機構，則可能在製定日益具有競爭力的研究和臨床項目方面落後於競爭對手。

長讀定序的發展軌跡將繼續受到化學和資訊學創新、商業模式的適應性以及使用者和供應商在標準、檢驗和培訓方面的合作能力的影響，從而支持其廣泛而可靠的應用。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將奈米孔定序與即時數據分析流程結合，用於快速疾病監測
  • 開發一種高保真長讀長定序平台，實現精確的相位測定和異構體分離。
  • 擴大可攜式定序儀的規模，用於偏遠地區的現場病原體檢測和疫情監測
  • 利用單分子長讀長定序進行全面的表觀遺傳學和甲基化譜分析
  • 將基於 CRISPR 的富集策略與長讀長定序相結合，用於標靶突變檢測
  • 長讀長技術在元基因組組組裝和抗生素抗藥性基因鑑定的新應用
  • 利用人工智慧演算法增強超長讀取資料集中的糾錯能力

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 長讀長定序市場（依產品和服務分類）

  • 消耗品
    • 流動池
    • 套件
    • 試劑
  • 裝置
    • 配件
    • 定序系統
  • 軟體和服務
    • 生物資訊服務
    • 數據分析軟體
    • 維護服務

9. 按技術分類的長讀長定序市場

  • 奈米孔定序
  • 單分子即時定序
  • 合成長讀定序

第10章 依應用分類的長讀長定序市場

  • 農業基因組學
  • 癌症基因體學
  • 臨床研究
  • 微生物基因體學

第11章 依最終用戶分類的長讀長定序市場

  • 學術的
  • 臨床診斷實驗室
  • 合約研究組織
  • 政府和監管機構
  • 製藥和生物技術

第12章 各地區的長讀長定序市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 長讀長定序市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國長讀長定序市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Pacific Biosciences of California, Inc.
    • Oxford Nanopore Technologies Limited
    • Illumina, Inc.
    • QIAGEN NV
    • F. Hoffmann-La Roche Ltd.
    • BGI Genomics Co., Ltd.
    • Genapsys, Inc.
    • Thermo Fisher Scientific Inc.
    • Hitachi High-Technologies Corporation
    • Element Biosciences, Inc.
Product Code: MRR-A26E0E574570

The Long Read Sequencing Market is projected to grow by USD 5,823.48 million at a CAGR of 27.01% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 859.80 million
Estimated Year [2025] USD 1,097.12 million
Forecast Year [2032] USD 5,823.48 million
CAGR (%) 27.01%

A concise and authoritative introduction explaining how long read sequencing has evolved into a strategic platform reshaping research, diagnostics, and applied genomics

Long read sequencing has moved from a specialized research capability into a strategic platform that is reshaping genomics research, clinical translational pipelines, and applied life sciences. The technology's ability to resolve complex genomic regions, phase alleles across long haplotypes, and detect structural variants and epigenetic marks in native molecules has unlocked applications that short-read methods cannot reliably address. As a result, research institutions, diagnostic labs, and industry adopters are re-evaluating technology stacks, workflows, and vendor relationships to capture the scientific and operational advantages offered by long reads.

In parallel, advances in chemistry, pore engineering, instrument design, and bioinformatics have increased read accuracy and throughput while simplifying sample preparation. These technical improvements, together with greater accessibility of analysis tools and cloud-enabled workflows, have lowered barriers to entry and broadened the user base beyond specialist sequencing centers. Consequently, organizations are moving from proof-of-concept studies to routine incorporation of long reads within programs in oncology, pathogen surveillance, crop improvement, and precision medicine.

Transitioning from experimental use to production-grade operations requires attention to reproducibility, regulatory readiness, and supply continuity. Institutions seeking to capitalize on long-read capability must therefore integrate robust data management, validation practices, and vendor-agnostic quality controls to ensure that the scientific gains translate into operational impact and credible clinical or regulatory outputs.

A forward-looking exploration of the technological, commercial, and workflow shifts that are redefining long read sequencing adoption and operational models across sectors

The landscape of long read sequencing is undergoing transformative shifts driven by technological maturation, workflow integration, and evolving end-user expectations. Hardware and chemistry advances have improved per-read accuracy and extended run stability, while modular instrument architectures permit scalable throughput from benchtop deployments to high-capacity centers. At the same time, real-time basecalling and native epigenetic detection have enabled new use cases where rapid turnaround and multi-layered molecular information are essential.

Concurrently, software ecosystems have shifted from bespoke academic scripts to enterprise-grade solutions that emphasize reproducibility, reproducible pipelines, and regulatory compliance. Cloud-native analysis frameworks, containerization, and standardized APIs are enabling cross-platform interoperability and easing barriers for clinical laboratories and CROs to adopt long-read workflows. Moreover, the commoditization of consumables and focus on sustainability in reagent manufacturing are influencing procurement strategies and long-term operating costs.

These changes are also manifesting in market behavior: vendors are diversifying commercial models to include instrument-as-a-service, subscription-based consumable plans, and integrated service offerings that bundle sequencing with bioinformatics and maintenance. As organizations reconsider long-term investments, attention is shifting toward total cost of ownership, lifecycle support, and the ability of technology partners to deliver validated workflows that meet regulatory and clinical-grade requirements.

An incisive assessment of how cumulative U.S. tariff measures through 2025 have reshaped procurement strategies, supply resilience, and vendor responses in the sequencing ecosystem

The cumulative tariff measures introduced in the United States through 2025 have introduced new dimensions to procurement, supply chain resilience, and sourcing strategies across the long read sequencing ecosystem. Increased duties on imported instruments and key reagents have prompted organizations to reassess vendor relationships and inventory policies to mitigate cost volatility and lead-time risk. In response, many stakeholders have prioritized diversification of suppliers, established buffer inventories for critical consumables like flow cells and specialized kits, and re-evaluated service contracts to lock in pricing and delivery windows.

Manufacturers and distributors have adapted by exploring onshore assembly, regional distribution centers, and partnerships with local manufacturers to reduce exposure to cross-border tariff impacts. For customers, the tariff environment has made lifecycle planning more complex: procurement cycles are extending as purchasers perform more thorough total-cost analyses and seek multi-year service agreements to manage post-tariff operating budgets. At the same time, some vendors have absorbed a portion of increased costs through pricing strategies that preserve installed-base loyalty, while others have accelerated investments in regional manufacturing to regain competitive positioning and shorten supply lines.

Overall, tariffs have emphasized the strategic value of supply-chain transparency, contractual flexibilities, and scenario planning. Organizations that proactively model tariff exposures, negotiate flexible terms, and develop alternative sourcing strategies are better positioned to sustain research continuity, protect clinical workflows, and maintain competitive timelines for product development and discovery.

A deep-dive synthesis of nuanced segmentation dynamics across product, technology, application, and end-user dimensions that inform strategic prioritization

Segment-level dynamics reveal differentiated drivers across products and services, technologies, applications, and end-user groups, and these distinctions are critical for strategic positioning. Within product and service segmentation, recurring revenue from consumables-including flow cells, kits, and reagents-remains a central operational consideration because consumable reliability and supply continuity directly affect throughput and experimental reproducibility. Investments in sequencing systems and supporting accessories shape capital planning cycles, whereas bioinformatics services, data analysis software, and maintenance services determine long-term operational support and regulatory readiness.

Across technology segmentation, nanopore sequencing has matured as a highly portable, real-time solution suited to field deployments and rapid surveillance, while single molecule real time sequencing has strengthened its niche where high per-read accuracy and circular consensus approaches are essential. Synthetic long read strategies continue to provide cost-effective alternatives for certain assembly tasks and large-genome projects where reconstructing long-range information from linked reads remains advantageous.

In terms of application, agricultural genomics benefits from long reads for structural variant detection and complex trait mapping, cancer genomics uses long-range phasing to resolve tumor heterogeneity, clinical research leverages comprehensive variant calling for translational studies, and microbial genomics relies on long reads for plasmid resolution and outbreak tracing. End users differ in priorities: academic centers focus on methodological innovation and novel use cases, clinical diagnostic laboratories emphasize validation, throughput, and compliance, contract research organizations offer turnkey sequencing services for multiple clients, government and regulatory bodies concentrate on surveillance and standardization, and pharmaceutical and biotechnology firms integrate long reads into target discovery and biomarker validation workflows.

A comparative regional intelligence perspective capturing how adoption drivers, regulatory frameworks, and commercial ecosystems diverge across major global regions

Regional dynamics are shaping adoption pathways and competitive priorities in distinct ways, reflecting differences in research infrastructure, regulatory environments, and commercial ecosystems. In the Americas, strong academic research networks, a dense concentration of clinical trial activity, and established vendor bases have accelerated adoption of high-accuracy long-read pipelines for oncology, neurogenomics, and microbial surveillance. This region also demonstrates mature public-private collaboration models that integrate sequencing into public health initiatives and translational programs.

In Europe, the Middle East & Africa, regulatory harmonization efforts and pan-European consortia are driving coordinated investments in reference genomes, surveillance networks, and cross-border data sharing. Research funding models in this region often emphasize collaborative infrastructure and standardized protocols, which in turn influence procurement cycles and demand for validated workflows and compliance-ready software. The presence of multiple language markets and diverse healthcare systems increases the importance of localized support and multi-jurisdictional regulatory expertise.

In the Asia-Pacific region, rapid capital deployment, expanding domestic manufacturing capabilities, and intensive activity in agricultural genomics and infectious disease surveillance have accelerated both adoption and innovation. Regional players often prioritize scalable platforms that balance throughput with cost-efficiency, and cross-border collaborations within the region are fostering ecosystem growth. Together, these regional distinctions inform go-to-market approaches, partnership models, and where to focus investments in local support and supply-chain resilience.

A strategic review of corporate behaviors showing how platform innovation, integrated services, and commercial model evolution are shaping competitive advantage

Corporate strategies within the long read sequencing domain are converging around several consistent themes: platform performance improvements, consumable lifecycle management, software and service integration, and collaborative partnerships. Leading instrument vendors are investing in chemistry innovations and pore design to reduce error profiles and improve throughput while expanding instrument form factors to address a broader range of laboratory footprints. Complementary to hardware advances, companies are accelerating development of analysis suites and managed services to remove barriers for clinical and industrial users who require validated, end-to-end workflows.

At the same time, commercial models are becoming more flexible. Subscription-based access to instruments, reagent bundling, and comprehensive support packages are emerging as viable alternatives to traditional capital purchase models. Strategic partnerships-spanning reagent manufacturers, cloud analytics providers, and academic consortia-are being used to extend addressable markets and accelerate application-specific validation, for example in oncology panels, crop genomics pipelines, and pathogen surveillance protocols. Service providers and CROs are expanding capabilities to include long-read-specific offerings, enabling customers to outsource sequencing and analysis while preserving data governance and quality.

Finally, companies are prioritizing supply-chain diversification and regional manufacturing to mitigate tariff exposure and logistics risk. Those that combine robust R&D roadmaps with transparent service level agreements and localized support infrastructures are increasingly attractive to large institutional buyers and enterprise customers seeking long-term partnerships.

Practical and actionable recommendations that balance supply resilience, bioinformatics investment, regulatory engagement, and customer-centric commercial models

Industry leaders should pursue a portfolio approach that balances near-term operational continuity with long-term strategic differentiation. First, strengthen supply-chain resilience by establishing multi-sourcing strategies for critical consumables such as flow cells and specialized reagents, negotiating multi-year commitments where appropriate, and evaluating regional distribution or assembly options to reduce exposure to cross-border tariff volatility. Second, prioritize investments in bioinformatics and data management: standardized, validated pipelines and robust data governance accelerate clinical adoption and support cross-institutional collaborations.

Third, align product and commercial models with distinct end-user needs by offering flexible procurement options for academic laboratories, validated turnkey solutions for clinical diagnostic customers, and scalable service packages for contract research organizations. Fourth, engage proactively with regulatory stakeholders and participate in standards-setting initiatives to ensure that new workflows meet evolving compliance expectations and to reduce time-to-validation for clinical applications. Fifth, invest in training and field support to lower adoption friction; hands-on education for laboratory staff and translational scientists will increase throughput and reduce error rates.

Taken together, these actions will enable organizations to capitalize on scientific advantages, secure operational continuity, and convert technical leadership into measurable outcomes for research programs, clinical services, and product development pipelines.

A transparent explanation of the evidence base and analytic processes used to synthesize technical trends, stakeholder perspectives, and segmentation-aligned insights

The research underpinning this executive summary combines structured secondary analysis, expert interviews, and cross-source validation to ensure rigor and relevance. Secondary analysis included a systematic review of peer-reviewed literature, patent activity, public product announcements, regulatory filings, and technical white papers to map technology trajectories and innovation hotspots. These sources were synthesized to identify emerging performance benchmarks, workflow shifts, and commercial model innovations.

Complementing the literature review, qualitative interviews were conducted with laboratory directors, technology adopters, procurement leads, and industry strategists to ground technical trends in operational realities and procurement constraints. Interview insights informed interpretations of vendor strategies, customer pain points, and the practical implications of tariff-driven supply-chain changes. Findings were triangulated across sources to reduce bias and confirm recurring themes.

Finally, segmentation frameworks were applied to align insights with product categories, technology types, application domains, and end-user profiles. Limitations include the evolving nature of instrument performance claims and potential lag in public disclosures for proprietary developments; accordingly, the methodology emphasizes transparency about assumptions and recommends follow-up validation for investment decisions or procurement commitments.

A concluding synthesis that clarifies the strategic imperatives and operational priorities required to capture the full value of long read sequencing innovations

Long read sequencing stands at an inflection point where technical progress, expanding application breadth, and evolving commercial practices are creating sustained strategic value for research institutions, clinical laboratories, and commercial life-science organizations. The capacity to deliver long-range genomic information, detect epigenetic marks natively, and resolve structural complexity is catalyzing advancements in oncology, microbial surveillance, agricultural breeding, and translational research. When combined with investments in validated analytics and resilient supply chains, these technical strengths translate into tangible operational and strategic benefits.

However, realizing this potential requires deliberate actions: prioritizing validated workflows for regulated settings, building redundancies in consumable sourcing, and investing in software and services that ensure reproducibility and regulatory compliance. Stakeholders that align procurement, R&D planning, and partnership strategies with these imperatives will be best positioned to extract sustained value. In contrast, organizations that delay integration of long-read data into their pipelines risk falling behind in capabilities that increasingly define competitive research and clinical programs.

Ultimately, the trajectory of long read sequencing will continue to be shaped by innovations in chemistry and informatics, by the adaptability of commercial models, and by the ability of users and vendors to collaborate on standards, validation, and training that underpin broad, reliable adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of nanopore sequencing with real-time data analysis pipelines for rapid disease surveillance
  • 5.2. Development of high-fidelity long read platforms enabling accurate phasing and isoform resolution
  • 5.3. Expansion of portable sequencers for in-field pathogen detection and outbreak monitoring in remote areas
  • 5.4. Adoption of single-molecule long read sequencing for comprehensive epigenetic and methylation profiling
  • 5.5. Integration of long read sequencing with CRISPR-based enrichment strategies for targeted variant detection
  • 5.6. Emerging use of long read technology for metagenomic assembly and antibiotic resistance gene identification
  • 5.7. Implementation of artificial intelligence algorithms to enhance error correction in ultra-long read datasets

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Long Read Sequencing Market, by Product & Service

  • 8.1. Consumables
    • 8.1.1. Flow Cells
    • 8.1.2. Kits
    • 8.1.3. Reagents
  • 8.2. Instruments
    • 8.2.1. Accessories
    • 8.2.2. Sequencing Systems
  • 8.3. Software & Services
    • 8.3.1. Bioinformatics Services
    • 8.3.2. Data Analysis Software
    • 8.3.3. Maintenance Services

9. Long Read Sequencing Market, by Technology

  • 9.1. Nanopore Sequencing
  • 9.2. Single Molecule Real Time Sequencing
  • 9.3. Synthetic Long Read Sequencing

10. Long Read Sequencing Market, by Application

  • 10.1. Agricultural Genomics
  • 10.2. Cancer Genomics
  • 10.3. Clinical Research
  • 10.4. Microbial Genomics

11. Long Read Sequencing Market, by End User

  • 11.1. Academic
  • 11.2. Clinical Diagnostic Laboratories
  • 11.3. Contract Research Organizations
  • 11.4. Government And Regulatory Bodies
  • 11.5. Pharmaceutical And Biotechnology

12. Long Read Sequencing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Long Read Sequencing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Long Read Sequencing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Pacific Biosciences of California, Inc.
    • 15.3.2. Oxford Nanopore Technologies Limited
    • 15.3.3. Illumina, Inc.
    • 15.3.4. QIAGEN N.V.
    • 15.3.5. F. Hoffmann-La Roche Ltd.
    • 15.3.6. BGI Genomics Co., Ltd.
    • 15.3.7. Genapsys, Inc.
    • 15.3.8. Thermo Fisher Scientific Inc.
    • 15.3.9. Hitachi High-Technologies Corporation
    • 15.3.10. Element Biosciences, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. LONG READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. LONG READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LONG READ SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LONG READ SEQUENCING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL LONG READ SEQUENCING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. GCC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. GCC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. GCC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2024 (USD MILLION)
  • TABLE 308. GCC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025-2032 (USD MILLION)
  • TABLE 309. GCC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 310. GCC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 311. GCC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 312. GCC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 313. GCC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 314. GCC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 315. GCC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. GCC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. GCC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. GCC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. GCC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. GCC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILL